| S4202 |
Verapamil HCl
|
Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent. Verapamil inhibits both permeability-glycoprotein (P-gp) and CYP3A4.
|
-
Cancer Cell, 2025, 43(4):776-796.e14
-
Nat Commun, 2025, 16(1):7115
-
Blood Sci, 2025, 7(2):e00236
|
|
| S2403 |
Tetrandrine
|
Tetrandrine, a bis-benzylisoquinoline alkaloid derived from Stephania tetrandra, is a calcium channel blocker.
|
-
PLoS Pathog, 2025, 21(8):e1013342
-
Pharmacol Res, 2024, 207:107314
-
mBio, 2024, e0228723.
|
|
| S1905 |
Amlodipine
|
Amlodipine (UK-48340) is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Cancer Medicine, 2024, e7291
-
Cancer Med, 2024, 13(11):e7291
|
|
| S1808 |
Nifedipine
|
Nifedipine is a dihydropyridine calcium channel blocker, used to lower hypertension and to treat angina.
|
-
Dis Model Mech, 2025, 18(6)dmm052220
-
J Immunother Cancer, 2024, 12(11)e009805
-
Laryngoscope Investig Otolaryngol, 2023, 8(5):1390-1400
|
|
| S1293 |
Cilnidipine
|
Cilnidipine is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Antioxidants, 2024, 38
-
Nat Commun, 2021, 12(1):3907
|
|
| S2721 |
Nilvadipine
|
Nilvadipine (ARC029, FR34235,FK235) is a potent calcium channel blocker with an IC50 of 0.03 nM.
|
-
Cell Death Differ, 2024, 10.1038/s41418-024-01418-y
-
J Immunother Cancer, 2024, 12(11)e009805
-
Nat Commun, 2022, 13-1:6117
|
|
| S2030 |
Flunarizine 2HCl
|
Flunarizine 2HCl (KW-3149, R14950) is a dihydrochloride salt form which is a calcium channel blocker with a Ki of 68 nM.
|
-
Science Advances, 2023, eadf2695
-
Sci Adv, 2023, 9(15):eadf2695
-
Science Advances, 2022, eabk2376
|
|
| S1356 |
Levetiracetam (UCB-L059)
|
Levetiracetam (UCB-L059, SIB-S1) is an anticonvulsant medication used to treat epilepsy and an agonist of muscarinic acetylcholine receptors (mAChR). This compound also modulates the presynaptic P/Q-type voltage-dependent calcium (Ca2+) channel.
|
-
Communications Medicine, 2025, 420
-
The Journal of Neuroscience, 2025, e2297242025
-
Front Neurosci, 2023, 17:1336026
|
|
| S1813 |
Amlodipine Besylate
|
Amlodipine Besylate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
|
-
Clin Exp Hypertens, 2025, 47(1):2515924
-
Function, 2023, zqad047
-
Front Pharmacol, 2022, 13:902305
|
|
| S1748 |
Nisoldipine
|
Nisoldipine (Sular, BAY K 5552) is a calcium channel blocker belonging to the dihydropyridines class, specific for L-type Cav1.2 with IC50 of 10 nM.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Biomed Pharmacother, 2022, 145:112432
-
iScience, 2022, 25(10):105068
|
|
| S8380 |
YM-58483 (BTP2)
|
YM-58483 (BTP2) is a blocker of store-operated Ca2+ entry (SOCE), which regulates the activation of non-excitable cells such as lymphocytes.
|
-
Mol Metab, 2025, 95:102114
-
Cell Death Discov, 2023, 9(1):100
-
bioRxiv, 2023, 10.1101/2023.07.31.551242
|
|
| S1425 |
Ranolazine 2HCl
|
Ranolazine 2HCl (RS-43285,RS 43285-193,Ranexa, renolazine,Ranolazine dihydrochloride) is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.
|
-
Autophagy, 2025, 1-20
-
J Immunother Cancer, 2024, 12(11)e009805
-
Cardiovascular Research, 2023, 2469–2481
|
|
| S1885 |
Felodipine
|
Felodipine (CGH-869) is a selective L-type Ca2+ channel blocker with IC50 of 0.15 nM.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Bioactive Materials, 2022, 272-289
-
Bioact Mater, 2022, 14:272-289
|
|
| S1747 |
Nimodipine
|
Nimodipine (BAY E 9736) is a dihydropyridine calcium channel blocker and an autophagy inhibitor, used in the treatment of high blood pressure.
|
-
Theranostics, 2025, 15(6):2624-2648
-
J Immunother Cancer, 2024, 12(11)e009805
-
Eye Vis (Lond), 2024, 11(1):37
|
|
| S1865 |
Diltiazem HCl
|
Diltiazem (Tiazac, RG 83606) HCl is a benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Function, 2023, zqad047
-
Anticancer Research, 2021, 6179-6190
|
|
| S1662 |
Isradipine
|
Isradipine (PN 200-110) is a potent and selective L-type voltage-gated calcium channel blocker, used to treat high blood pressure.
|
-
Cancer Res Commun, 2025, 10.1158/2767-9764.CRC-24-0433
-
J Cell Sci, 2022, 135(14)jcs260249
-
Environ Toxicol Chem, 2021, 10.1002/etc.5018
|
|
| S2482 |
Manidipine 2HCl
|
Manidipine 2HCl (CV-4093) is a HCl salt form of Manidipine, which is a calcium channel blocker with IC50 of 2.6 nM, used clinically as an antihypertensive. Phase 4.
|
-
Cell Death Differ, 2024, 10.1038/s41418-024-01418-y
-
Adv Sci (Weinh), 2023, 10(11):e2205500
-
Front Microbiol, 2023, 14:1177391
|
|
| S2481 |
Manidipine
|
Manidipine(CV-4093,(±)-Manidipine) is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Frontiers of Medicine, 2022, 467-482
-
Antiviral Research, 2018, 130-136
|
|
| S2080 |
Clevidipine Butyrate
|
Clevidipine Butyrate(Cleviprex) is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure.
|
-
Cell Death Differ, 2024, 10.1038/s41418-024-01418-y
-
J Immunother Cancer, 2024, 12(11)e009805
-
UNIVERSITY OF PÉCS, 2023,
|
|
| S2017 |
Benidipine HCl
|
Benidipine HCl (KW-3049,(±)- Benidipine) is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Cell Discov, 2020, 6(1):96
-
ACS Infect Dis, 2020, acsinfecdis.0c00486
|
|
| S2491 |
Nitrendipine
|
Nitrendipine (Bayotensin) is a dihydropyridine calcium channel blocker with an IC50 of 95 nM.
|
-
Biochem Biophys Res Commun, 2025, 786:152756
-
Nat Commun, 2024, 15(1):8708
-
Cell Death Differ, 2024, 10.1038/s41418-024-01418-y
|
|
| S3053 |
Azelnidipine
|
Azelnidipine (UR-12592) is a dihydropyridine calcium channel blocker. This compound is used for the treatment of hypertension.
|
-
Cellular and Molecular Gastroenterology and Hepatology, 2022, 483-500
-
Cell Mol Gastroenterol Hepatol, 2021, S2352-345X(21)00196-X
-
Environ Toxicol Chem, 2021, 10.1002/etc.5018
|
|
| S4648 |
Dantrolene sodium hemiheptahydrate
|
Dantrolene sodium hemiheptahydrate (Dantrium) is a skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber.
|
-
Cardiovasc Res, 2021, 117(4):1091-1102
-
Oxid Med Cell Longev, 2021, 2021:8810698
-
Oxidative Medicine and Cellular Longevity, 2021, 8810698
|
|
| S1799 |
Ranolazine
|
Ranolazine (CVT 303, RS 43285-003) is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina.
|
-
Sci Rep, 2023, 10.1038/s41598-023-47540-8
-
Cancer Cell, 2022, S1535-6108(22)00312-9
|
|
| S1994 |
Lacidipine
|
Lacidipine (GX-1048, GR-43659X, SN-305) is a L-type calcium channel blocker, used for treating high blood pressure.
|
-
Cell Death Differ, 2024, 10.1038/s41418-024-01418-y
-
J Immunother Cancer, 2024, 12(11)e009805
|
|
| S2573 |
Tetracaine HCl
|
Tetracaine HCl (Amethocaine hydrochloride) is a hydrochloride salt form of tetracaine which is a potent local anaesthetic and a channel function allosteric inhibitor.
|
-
PLoS Pathogens, 2023, e1011295
-
PLoS Pathog, 2023, 19(3):e1011295
|
|
| S5255 |
Nicardipine
|
Nicardipine is a potent calcium channel blockader with marked vasodilator action.
|
-
Front Pharmacol, 2025, 16:1539032
-
Cell Chem Biol, 2021, S2451-9456(21)00442-6
|
|
| S4626 |
Ethosuximide
|
Ethosuximide(Zarontin) is a succinimide anticonvulsant, used mainly in absence seizures; A calcium channel blocker.
|
-
Nature, 2018, 554(7692):317-322
-
Brain, 2017, 669-683
|
|
| S4597 |
Lercanidipine hydrochloride
|
Lercanidipine is a calcium channel blocker of the dihydropyridine class.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
J Phys Chem B, 2013, 117(23):6868-73
|
|
| S4977 |
Efonidipine
|
Efonidipine (NZ-105) is an L- and T-type calcium channel blocker leading to vasodilation and decreased automaticity of the heart. It also suppresses aldosterone secretion from the adrenal.
|
-
Biomol Ther (Seoul), 2022, 30(5):455-464
-
Biomolecules & Therapeutics, 2022, 455-464
|
|
| S4084 |
Lomerizine 2HCl
|
Lomerizine dihydrochloride (KB-2796) is a relatively new L- and T-type calcium channel blocker used in the treatment of migraine.
|
-
Sci Rep, 2025, 15(1):11355
-
Nat Commun, 2024, 15(1):8708
|
|
| S3674 |
Levamlodipine
|
Levamlodipine (S-amlodipine) is a pharmacologically active enantiomer of amlodipine which belongs to the dihydropyridine group of calcium channel blocker. It acts on the L-type of calcium channels and its treatment results in vasodilation and a fall in blood pressure.
|
-
Oncogene, 2021, 40(6):1128-1146
-
Open Access Macedonian Journal of Medical Sciences, 2021, 505-509
|
|
| S4727 |
Cinnarizine
|
Cinnarizine (Stugeron, Dimitronal, Stutgin, Cinarizine) is a medication derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.
|
-
Science Advances, 2022, eabk2376
-
Sci Adv, 2022, 8(15):eabk2376
|
|
| S3045 |
Cinepazide maleate
|
Cinepazide maleate is a maleate salt form of cinepazide which is a vasodilator.
|
-
J Immunother Cancer, 2024, 12(11)e009805
|
|
| S5966 |
Amlodipine maleate
|
Amlodipine (Amvaz, UK-48340) maleate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
|
-
Front Pharmacol, 2022, 13:902305
|
|
| S6834 |
Zegocractin (CM-4620)
|
Zegocractin (CM 4620) is an inhibitor of calcium-release activated calcium-channel (CRAC channel). CM4620 inhibits Orai1/STIM1-mediated Ca2+ currents and Orai2/STIM1-mediated currents with IC50 of near 120 nM and 900 nM, respectively.
|
-
Elife, 2023, 12e81288
|
|
| S5514 |
Lanthanum(III) chloride heptahydrate
|
Lanthanum(III) chloride is the inorganic compound used in biochemical research to block the activity of divalent cation channels, mainly calcium channels.
|
-
J Surg Res, 2021, 263:236-244
|
|
| S6473 |
Pinaverium bromide
|
Pinaverium bromide (Icosapentaenoic acid) acts as a calcium channel blocker and is useful for functional gastrointestinal disorders.
|
-
Cell Rep, 2024, 43(11):114952
|
|
| S9842 |
MCU-i4
|
MCU-i4 is a negative modulator of the mitochondrial calcium uniporter (MCU) complex that directly binds a specific cleft in MICU1 and decreases mitochondrial Ca2+ influx.
|
-
PLoS Pathog, 2025, 21(1):e1012872
|
|
| S0000 |
Cav 2.2 blocker 1
|
Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.
|
|
|
| E8077 |
ML218
|
ML218 is a potent, selective, and orally active inhibitor of T-type Ca²⁺ channels (Cav3.1, Cav3.2, and Cav3.3), with IC50 of 310 nM for Cav3.2 and 270 nM for Cav3.3. It effectively suppresses burst activity in subthalamic nucleus (STN) neurons.
|
|
|
| E0778 |
o-3M3FBS
|
O-3M3FBS, the negative control of m-3M3FBS, inhibits inward and outward currents via mechanisms independent of PLC acting in an antagonistic manner, reversibly inhibits delayed rectifier K+ channels, increases in [Ca2+](i) in an agonistic manner with m-3M3FBS.
|
|
|
| S0535 |
FK962
|
FK962, a derivative of FK960 with putative anti-dementia properties, significantly enhances high K+-evoked somatostatin release from rat hippocampal slices at 1-1000 nM, also significantly reduces somatostatin-induced inhibition of Ca2+ channels at 1-100 nM in single rat hippocampal neurons.
|
|
|
| E5930New |
REM127
|
REM127 is a small molecule that restores calcium homeostasis by stabilizing the septin cytoskeleton, thereby preventing pathological calcium influx in models of tauopathies. It improves synaptic plasticity, reduces tau and Aβ pathology, and rescues memory function in disease models. It exhibits a potential for treating Alzheimer’s disease and frontotemporal dementia.
|
|
|
| S5279 |
Fendiline hydrochloride
|
Fendiline hydrochloride is the hydrochloride salt form of Fendiline, which is an L-type calcium channel blocker and also a specific inhibitor of K-Ras plasma membrane targeting with no detectable effect on the localization of H- and N-Ras.
|
|
|
| S3845 |
Panaxadiol
|
Panaxadiol (20(R)-Panaxadiol) is a triterpene sapogenin originally found in species of Panax (ginseng) and exhibits anticancer, cardioprotective, anti-arrhythmic, and antioxidative activities. This compound inhibits Ca2+ channels, decreasing channel open time and open state probability in vitro and displaying anti-arrhythmic potential.
|
|
|
| S5898 |
Efonidipine hydrochloride monoethanolate
|
Efonidipine (NZ-105) hydrochloride monoethanolate is an L- and T-type calcium channel blocker leading to vasodilation and decreased automaticity of the heart. Efonidipine hydrochloride monoethanolate also suppresses aldosterone secretion from the adrenal.
|
|
|
| E1368 |
PD173212
|
PD173212(Compound 11) is a selective N-type voltage sensitive calcium channel (VSCC) blocker, with an IC50 of 36 nM in IMR-32 assays.
|
|
|
| S9017 |
Columbianadin
|
Columbianadin (Zosimin, 2-Butenoic acid), a natural coumarin from Angelica decursiva, is known to have various biological activities including calcium-channel blocking activity, cytotoxic activity against various cancer cell lines, analgesic activities, intestinal absorption and transportation, anti-inflammatory and anti-cancer effects.
|
|
|
| S6920 |
SEA0400
|
SEA0400 is a selective and potent inhibitor of the Na+-Ca2+ exchanger (NCX) that inhibits Na+-dependent Ca2+ uptake in cultured neurons, astrocytes, and microglia with IC50 of 33 nM, 5.0 nM and 8.3 nM, respectively. This compound prevents sodium nitroprusside (SNP) from increasing ERK and p38 MAPK phosphorylation and production of reactive oxygen species (ROS) in an extracellular Ca(2+)-dependent manner.
|
|
|
| E0826 |
Levamlodipine Besylate
|
Levamlodipine Besylate is a powerful dihydropyridine calcium channel blocker, possessing vasodilation properties and used in the treatment of hypertension and angina.
|
|
|
| S3682 |
Ethyl 3-Aminobenzoate methanesulfonate
|
Ethyl 3-Aminobenzoate (Ethyl m-Aminobenzoate, NSC 93790, Tricaine) can block the generation of action potentials via voltage-dependent Na+-channels and usually used for anesthesia, sedation, or euthanasia of fish.
|
|
|
| E0334 |
BAMB-4
|
BAMB-4 (ITPKA-IN-C14) is a new type of membrane permeable ITPKA inhibitor, and IC50 is 37 μM in the Kinase ADP-Glo assay.
|
|
|
| S9400 |
Rhynchophylline
|
Rhynchophylline (Mitrinermine), an active component isolated from species of the genus Uncaria, acts as a calcium channel blocker and is widely used in traditional Chinese medicine mainly for treating ailments of central nervous and cardiovascular systems, such as lightheadedness, convulsions, numbness, and hypertension.
|
|
|
| S5567 |
Trimethadione
|
Trimethadione is an oxazolidinedione anticonvulsant and often used to treat epileptic conditions that are resistant to other treatments.
|
|
|
| S9566 |
Bepridil hydrochloride monohydrate
|
Bepridil hydrochloride monohydrate(CERM 1978) is an anti-anginal drug classified as a calcium channel blocker. It also blocks multiple other ion channels, including sodium and potassium channels.
|
|
|
| S0452 |
NP118809
|
NP118809(39-1B4) is a potent N-type calcium channel blocker, with an IC50 of 0.11 μM, also less potently inhibits L-type calcium channel with an IC50 of 12.2 μM.
|
|
|
| S2975 |
CarboxyaMidotriazole orotate
|
Carboxyamidotriazole Orotate (L-651582 Orotate) is the orotate salt form of Carboxyamidotriazole (CAI), an orally bioavailable signal transduction inhibitor. Carboxyamidotriazole Orotate is a cytostatic inhibitor of nonvoltage-operated calcium channels and calcium channel-mediated signaling pathways. Carboxyamidotriazole Orotate inhibits angiogenesis, tumor growth, invasion, and metastasis.
|
|
|
| E2984 |
GSK-7975A
|
GSK-7975A is a potent and orally available inhibitor of CRAC channel. It reduces FcεRI-dependent Ca2+ influx and reduces the release of histamine, leukotriene C4, and cytokines (IL-5/-8/-13 and TNFα).
|
|
|
| E2993 |
Ruthenium Red
|
Ruthenium red (Ammoniated ruthenium oxychloride) is a polycationic dye, which is a L-type calcium current (ICa) blocker. It is widely used for electron microscopy (EM) of cells, tissues and vegetative bacteria. Ruthenium red strongly reacts with phospholipids and fatty acids and binds to acidic mucopolysaccharides.
|
|
|
| S1573 |
Fasudil (HA-1077) Hydrochloride
|
Fasudil HCl, a potent and selective inhibitor of Rho kinase, displays less potent inhibiton over PKA, PKG, PKC and MLCK with Ki of 1.6, 1.6, 3.3, and 36 μM in cell-free assays, respectively. Fasudil is also a calcium channel blocker.
|
-
Stem Cell Res Ther, 2025, 16(1):597
-
Transl Oncol, 2025, 51:102209
-
J Immunother Cancer, 2024, 12(11)e009805
|
|
| S1811 |
Amiloride HCl
|
Amiloride HCl is a selective T-type calcium channel blocker, an epithelial sodium channel blocker and a selective inhibitor of urokinase plasminogen activator (uPA)(Ki=7 μM).
|
-
J Extracell Vesicles, 2024, 13(4):e12426
-
Virus Res, 2024, 339:199258
-
J Clin Invest, 2023, 10.1172/JCI163402
|
|
| S6657 |
2-APB (2-Aminoethyl Diphenylborinate)
|
2-Aminoethyl Diphenylborinate (2-APB) is an IP3 receptor inhibitor and regulates IP3-induced calcium release. It also inhibits the SOC channel activity and, at higher concentrations, inhibits TRP channel.
|
-
Cell Prolif, 2025, e70120.
-
PLoS Pathog, 2025, 21(1):e1012872
-
Liver Int, 2025, 45(10):e70341
|
|
| S3931 |
Ginsenoside Rd
|
Ginsenoside Rd (Panaxoside Rd, Sanchinoside Rd), a minor ginseng saponin, has several pharmacological activities such as immunosuppressive activity, anti-inflammatory activity, immunological adjuvant, anti-cancer activity and wound-healing activity. This compound inhibits TNFα-induced NF-κB transcriptional activity with an IC50 of 12.05±0.82 μM in HepG2 cells. It inhibits expression of COX-2 and iNOS mRNA. This chemical also inhibits Ca2+ influx. It inhibits CYP2D6, CYP1A2, CYP3A4, and CYP2C9, with IC50s of 58.0±4.5 μM, 78.4±5.3 μM, 81.7±2.6 μM, and 85.1±9.1 μM, respectively.
|
-
The American Journal of Chinese Medicine, 2023, 91-105
-
Journal of Ginseng Research, 2022, 700-709
-
Drug Design, Development and Therapy, 2022, 2767-2782
|
|
| S6847 |
ML-9 HCl
|
ML-9 HCl (ML-9 hydrochloride) is a selective and potent inhibitor of Akt kinase, myosin light chain kinase (MLCK) and stromal interaction molecule 1 (STIM1). This compound is also a potent inhibitor of Ca2+-permeable channels. It is a lysosomotropic agent targeting autophagy and cell death.
|
-
Cell Mol Life Sci, 2025, 82(1):201
-
Cellular and Molecular Life Sciences, 2025, 201
-
PLoS Pathog, 2023, 19(3):e1011295
|
|
| S2114 |
Dronedarone HCl
|
Dronedarone HCl (SR33589) is a multichannel blocker targeting potassium channel, sodium channel and calcium channel, used as an antiarrhythmic drug for treatment of atrial fibrillation (AF).
|
-
Cancers (Basel), 2022, 14(19)4883
-
Chem Res Toxicol, 2021, 10.1021/acs.chemrestox.1c00127
-
Cell Syst, 2019, 8(2):97-108
|
|
| S4181 |
Nicardipine HCl
|
Nicardipine HCl (RS-69216,YC-93) is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.
|
-
Frontiers in Pharmacology, 2025, 1539032
-
Cell Discovery, 2020, 96
-
Cell Discov, 2020, 6(1):96
|
|
| S3766 |
Tanshinone IIA sulfonate sodium
|
Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of tanshinone IIA isolated as the main pharmacologically active natural compound from a traditional Chinese herbal medicine, the dried root of Salvia miltiorrhiza Bunge known as Danshen. Sodium tanshinone IIA sulfonate (STS) is a potent negative allosteric modulator of the human purinergic receptor P2X7. Sodium tanshinone IIA sulfonate (STS) inhibits the activity of CYP3A4 and store-operated Ca2+ entry (SOCE) through store-operated Ca2+ channels (SOCC) via downregulating the expression of transient receptor potential canonical proteins (TRPC).
|
-
Journal of Inflammation Research, 2022, 6293-6306
-
J Inflamm Res, 2022, 15:6293-6306
|
|
| E1259 |
DNQX
|
DNQX is an AMPA receptor antagonist that prevents excess calcium influx via voltage-gated calcium channels.
|
|
|
| S3242 |
Loureirin B
|
Loureirin B (LB, LrB), a flavonoid extracted from Dracaena cochinchinensis, is an inhibitor of PAI-1 with IC50 of 26.10 μM. This compound downregulates p-ERK and p-JNK in TGF-β1-stimulated fibroblasts. It promotes insulin secretion mainly through increasing Pdx-1, MafA, intracellular ATP level, inhibiting the KATP current, influx of Ca2+ to the intracellular.
|
|
|
| S3700 |
DHBP dibromide
|
DHBP (1,1'-diheptyl-4,4'-bipyridinium), a viologen for electrochromic memory display agent, inhibits the calcium release induced by 2 mM caffeine and 2 μg/ml polylysine with an IC50 value of 5 μg/ml and 4 μg/ml respectively.
|
|
|
| S9315 |
Praeruptorin A
|
Praeruptorin A, a naturally existing pyranocumarin, is isolated from the dried root of Peucedanum praeruptorum Dunn. This compound inhibits p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation. It can significantly upregulates multidrug resistance-associated protein 2 expression via the constitutive androstane receptor-mediated pathway in vitro, and this should be taken as an herb-drug interaction.
|
|
|
| S3883 |
Protopine
|
Protopine (Corydinine, Fumarine, Biflorine, Macleyine), an alkaloid present in different plants, has been shown to exhibit a number of activities, such as inhibition of calcium influx through both voltage and receptor-operated channels and inhibition of rabbit blood platelet aggregation. It also possesses anti-cholinergic and anti-histaminic as well as anti-bacterial activities.
|
|
|
| S0016 |
SN-6
|
SN-6 is a selective Na+/Ca2+ exchanger (NCX) inhibitor. This compound inhibits NCX1, NCX2, and NCX3 with IC50 of 2.9 μM, 16 μM and 8.6 μM, respectively. It abolishes acetylcholine (ACh)-induced vasodilation.
|
|
|